OPKO HEALTH, INC.

(OPK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Dragged Lower in Broad-Based Equities Selloff

01/24/2022 | 01:33pm EDT


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
MEDIWOUND LTD. -3.97% 1.815 Delayed Quote.-19.92%
NASDAQ COMP. 2.36% 11933.77 Real-time Quote.-25.45%
OPKO HEALTH, INC. 5.39% 3.135 Delayed Quote.-38.25%
PFIZER, INC. 1.34% 51.345 Delayed Quote.-14.19%
TIZIANA LIFE SCIENCES PLC 3.87% 0.89 Delayed Quote.-10.75%
All news about OPKO HEALTH, INC.
05/13OPKO HEALTH, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equit..
AQ
05/10Piper Sandler Adjusts OPKO Health's Price Target to $5 From $6, Reiterates Overweight R..
MT
05/09OPKO HEALTH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESU..
AQ
05/09OPKO Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/09Earnings Flash (OPK) OPKO HEALTH Posts Q1 Revenue $329.2M, vs. Street Est of $331.5M
MT
05/09OPKO HEALTH : Q1 Earnings Snapshot
AQ
05/09TRANSCRIPT : OPKO Health, Inc., Q1 2022 Earnings Call, May 09, 2022
CI
05/09OPKO Health Reports 2022 First Quarter Business Highlights and Financial Results
AQ
05/09Opko Health Buys ModeX Therapeutics for $300 Million
MT
05/09OPKO Health Acquires ModeX Therapeutics, Gains Proprietary Immunotherapy Technology wit..
AQ
More news
Analyst Recommendations on OPKO HEALTH, INC.
More recommendations
Financials (USD)
Sales 2022 1 127 M - -
Net income 2022 -168 M - -
Net Debt 2022 - - -
P/E ratio 2022 -12,6x
Yield 2022 -
Capitalization 2 024 M 2 024 M -
Capi. / Sales 2022 1,80x
Capi. / Sales 2023 1,83x
Nbr of Employees 5 767
Free-Float 59,9%
Chart OPKO HEALTH, INC.
Duration : Period :
OPKO Health, Inc. Technical Analysis Chart | OPK | US68375N1037 | MarketScreener
Technical analysis trends OPKO HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 2,97 $
Average target price 6,50 $
Spread / Average Target 119%
EPS Revisions
Managers and Directors
Phillip Frost Chairman & Chief Executive Officer
Jon Roger Cohen Director & Senior Vice President
Adam E. Logal CFO, Treasurer, Chief Accounting Officer & SVP
Jane H. Hsaio Vice Chairman & Chief Technical Officer
Steven D. Rubin Director & Executive Vice President-Administration
Sector and Competitors
1st jan.Capi. (M$)
OPKO HEALTH, INC.-38.25%2 024
JOHNSON & JOHNSON4.10%468 600
PFIZER, INC.-14.19%284 304
ABBVIE INC.14.82%274 733
ELI LILLY AND COMPANY8.38%269 490
ROCHE HOLDING AG-14.96%260 807